FLETA BOLUS

Main information

  • Trade name:
  • FLETA BOLUS 10ML V. INJ
  • Dosage:
  • 2MG/ML
  • Pharmaceutical form:
  • INJ
  • Composition:
  • 10ML V.
  • Medicine domain:
  • Humans
  • Medicine type:
  • Allopathic drug

Documents

Localization

  • Available in:
  • FLETA BOLUS 10ML V. INJ
    India
  • Language:
  • English

Other information

Status

  • Source:
  • Central Drugs Standard Control Organization
  • Last update:
  • 09-08-2016

6-4-2018

MAGMILAX BOLUS (Magnesium Oxide) Tablet [Vedco, Inc.]

MAGMILAX BOLUS (Magnesium Oxide) Tablet [Vedco, Inc.]

Updated Date: Apr 6, 2018 EST

US - DailyMed

20-3-2018

Integrilin (Glaxo Group Ltd)

Integrilin (Glaxo Group Ltd)

Integrilin (Active substance: Eptifibatide) - Centralised - Yearly update - Commission Decision (2018)1742 of Tue, 20 Mar 2018

Europe -DG Health and Food Safety

28-2-2018

UTERINE BOLUS (Urea) Tablet [DURVET, INC.]

UTERINE BOLUS (Urea) Tablet [DURVET, INC.]

Updated Date: Feb 28, 2018 EST

US - DailyMed

28-2-2018

RUMEN BOLUS (Magnesium Oxide) Tablet [Durvet, Inc.]

RUMEN BOLUS (Magnesium Oxide) Tablet [Durvet, Inc.]

Updated Date: Feb 28, 2018 EST

US - DailyMed

27-2-2018

MVT BOLUS (Magnesium Oxide) Tablet [Henry Schein Animal Health]

MVT BOLUS (Magnesium Oxide) Tablet [Henry Schein Animal Health]

Updated Date: Feb 27, 2018 EST

US - DailyMed

12-1-2018

EPTIFIBATIDE Injection, Solution [Akorn, Inc.]

EPTIFIBATIDE Injection, Solution [Akorn, Inc.]

Updated Date: Jan 12, 2018 EST

US - DailyMed

23-6-2017

ASPIRIN BOLUS (Acetylsalicylic Acid) Tablet [MWI Veterinary Supply, Inc.]

ASPIRIN BOLUS (Acetylsalicylic Acid) Tablet [MWI Veterinary Supply, Inc.]

Updated Date: Jun 23, 2017 EST

US - DailyMed

19-6-2017

EPTIFIBATIDE Injection [AuroMedics Pharma LLC]

EPTIFIBATIDE Injection [AuroMedics Pharma LLC]

Updated Date: Jun 19, 2017 EST

US - DailyMed

15-6-2017

Single-Shot IDegLira Bests Basal-Bolus Insulin Regimen in Diabetes

Single-Shot IDegLira Bests Basal-Bolus Insulin Regimen in Diabetes

A single daily injection of fixed-dose insulin degludec/liraglutide (IDegLira) (Xultophy 100/3.6, Novo Nordisk) could offer an alternative to multiple daily insulin injections for patients with type 2 diabetes who don't achieve glucose targets with basal insulin alone, new company-sponsored research shows.

US - RxList